Every once and a while we get a clear example of the gulf between those battling over important public policy issues and can understand why the public and policy makers are confused by resulting charges and counter charges. Last week was a good illustration.
{iframe}http://www.ipwatchdog.com/2014/11/30/around-and-around-the-drug-development-debate/id=52308/{/iframe}